Rbf Capital, LLC Enzo Biochem Inc Transaction History
Rbf Capital, LLC
- $2.03 Billion
- Q2 2025
A detailed history of Rbf Capital, LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Rbf Capital, LLC holds 150,000 shares of ENZ stock, worth $82,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,000
Previous 250,359
40.09%
Holding current value
$82,500
Previous $92,000
10.87%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ENZ
# of Institutions
14Shares Held
4.29MCall Options Held
0Put Options Held
0-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
-
Black Rock Inc. New York, NY955KShares$525,2620.0% of portfolio
-
Squarepoint Ops LLC New York, NY141KShares$77,3500.0% of portfolio
-
Lepercq Multi Asset Fund Hamilton, D0123KShares$67,6500.06% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...